Skip to main content
logo
Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,190.00
+100.00 (1.96%)
Last updated: Aug 3, 2026, 1:36 PM KST

Kyongbo Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
347.4182.294,6392,974610.59-7,495
Depreciation & Amortization
13,64613,20412,40811,69911,93612,757
Loss (Gain) From Sale of Assets
-23.86149.126.2911.08-121.98-58.68
Asset Writedown & Restructuring Costs
----43.11--
Loss (Gain) From Sale of Investments
72.39-12.02130228.13134.663,836
Loss (Gain) on Equity Investments
-4,155-4,1511,376376.33463.7285.58
Provision & Write-off of Bad Debts
273.6956.89397.06186.82-893.1-
Other Operating Activities
1,234888.68-374.743,093950.55-2,099
Change in Accounts Receivable
-10,137-11,8544,466-6,243-3,1524,700
Change in Inventory
12,3439,861-17,810-16,280-274.293,933
Change in Accounts Payable
-150.4-60.28-8,0798,256-1,5622,097
Change in Other Net Operating Assets
-2,218-809.412,991586.162,034212.73
Operating Cash Flow
11,2337,456149.124,84410,12717,968
Operating Cash Flow Growth
-4899.82%-96.92%-52.16%-43.64%-13.60%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-50,956-41,538-12,697-9,693-12,874-17,506
Sale of Property, Plant & Equipment
32.627.117.8621.88272.27101.9
Sale (Purchase) of Intangibles
-390.87-55.92-478.46-949.21-310.13-817.33
Investment in Securities
1,6815,895-749.48-3,183-1,6802,123
Other Investing Activities
102.81-2,308-726-464.64-285.81-74.59
Investing Cash Flow
-49,531-37,981-14,633-14,268-14,877-16,174

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-233,973184,082144,266148,765145,265
Long-Term Debt Issued
-24,000----
Total Debt Issued
274,172257,973184,082144,266148,765145,265
Short-Term Debt Repaid
--221,921-167,941-135,050-140,098-151,259
Long-Term Debt Repaid
--1,096-1,078-861.44-882.17-837.12
Total Debt Repaid
-231,310-223,017-169,019-135,911-140,981-152,097
Net Debt Issued (Repaid)
42,86234,95615,0638,3547,784-6,831
Dividends Paid
-1,195-1,195-1,195-1,195-1,195-2,391
Other Financing Activities
--0--0-0-
Financing Cash Flow
41,66633,76113,8687,1596,589-9,222

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-79.81-134.81266.24392.98219.91278.45
Net Cash Flow
3,2883,101-349.31-1,8712,058-7,149

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-39,723-34,083-12,547-4,849-2,747461.73
Free Cash Flow Growth
------94.72%
Free Cash Flow Margin
-14.73%-12.90%-5.26%-2.24%-1.40%0.27%
Free Cash Flow Per Share
-1662.48-1425.64-524.69-202.82-116.9719.34
Levered Free Cash Flow
-29,941-31,501-13,901-6,351-5,058904.92
Unlevered Free Cash Flow
-27,260-28,819-11,220-4,225-4,0141,640

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4,7244,5224,3123,4071,5511,190
Cash Income Tax Paid
434469.95208.49200.925.29976.16
Change in Working Capital
-162.06-2,863-18,433-13,681-2,95310,942